Word

BIOPALETTE

Status

Pending

Status Code

630

Status Date

Friday, March 22, 2024

Serial Number

98463652

Mark Type

4000

Filing Date

Friday, March 22, 2024

Trademark Owner History

Bio Palette Co., Ltd.

Classifications

5 pharmaceutical preparations produced by genome or gene editing operation for treatment, diagnosis or prevention of any human diseases or conditions; chemical reagents for medical purposes produced by genome or gene editing operation; cultures of microorganisms for medical or veterinary use produced by genome or gene editing operation; living cells, microorganisms, proteins, peptides, nucleic acid, and combinations thereof for medical or veterinary purposes produced by genome or gene editing operation; biological cells for surgical implantation produced by genome or gene editing operation; pharmaceutical and biological preparations, and diagnostic products based on gene, genome and cellular editing, modulation, modification, engineering, regulation, repair and therapy for use in treatment, diagnosis or prevention of any human diseases or conditions, all produced by genome or gene editing operation; cultures of microorganisms for medical or veterinary purposes, produced by genome or gene editing operation; biological tissue cultures for medical or veterinary purposes, produced by genome or gene editing operation

1 chemicals for use in industry and science; chemical reagents for use in genetic research other than for medical or veterinary purposes; chemical reagents for use in genetic research in the field of genome or gene editing other than for medical or veterinary purposes; chemical substances produced by genome or gene editing operation for analyses in laboratories, other than for medical or veterinary purposes; chemical reagent for separation and production of gene editing substances for non-medical purposes; biotechnologically-formed genes for use in the manufacture of agricultural seeds produced by genome or gene editing operation; cultures of microorganisms produced by genome or gene editing operation, other than for medical or veterinary use; reagents for scientific or research use in the field of genome or gene editing; genes for use in the manufacture of agricultural seeds; cultures of microorganisms, other than for medical or veterinary use

31 crop seeds; plant seeds; crop seeds produced by genome or gene editing operation; plant seeds produced by genome or gene editing operation; crop seeds in which herbicide tolerance genes are incorporated by genome or gene editing operation; plant seeds in which herbicide tolerance genes are incorporated by genome or gene editing operation; vegetable seeds for planting produced by genome or gene editing operation; seeds for agricultural purposes; vegetable seeds for planting; seeds for planting; genetically modified seeds including seeds for agricultural purposes, flower seeds, seeds for planting, or vegetable seeds for planting

42 research and development in the field of bacteriology, cytology, antibody technology, chemistry, immunology, and gene expression systems; scientific research in the field of genetics and genetic engineering; DNA screening for scientific research purposes; research and development and advisory services relating thereto in the fields of protein, antibody, and microorganism study, and the study of cells; structural and functional analysis of the genome with genome editing technology; DNA screening for scientific research purposes with genome editing technology; research and development, advisory services relating thereto in the field of genome editing technology; scientific research in the field of genetics and genetic engineering with genome editing technology; testing, inspection or research of pharmaceuticals, cosmetics or foodstuffs, all with genome editing technology; development of pharmaceuticals, cosmetics or foodstuffs, all with genome editing technology; technical advisory services relating to development of pharmaceuticals, cosmetics or foodstuffs, all with genome editing technology; information providing services relating to the development of pharmaceuticals, cosmetics or foodstuffs, all with genome editing technology; testing, examination or research relating to medical treatment or medical technology with genome editing technology; information providing services for testing, examination or research relating to medical treatment or medical technology with genome editing technology; testing or research relating to genome or gene to which genome editing technology is applied; scientific and medical research and survey in relation to bioinformatic tools in the fields of editing, modulation, modification, engineering, regulation, repair and therapy of gene, genome and cells to develop human pharmaceutical, biological preparations, and diagnostic products and services; scientific and technical research and development of bioinformatic tools in the fields of editing, modulation, modification, engineering, regulation, repair and therapy of gene, genome and cells to develop human pharmaceutical, biological preparations, and diagnostic products and services; research and development for the pharmaceutical industry and biotechnology industry with genome editing technology; research and development of biotechnology for others; research and development of genome editing technology for others; development of pharmaceutical preparations and medicines; biotechnology research; research and development in the field of genomics and biotechnology; technical advisory services in the field of genomics and biotechnology; structural and functional analysis of genomes; scientific and medical research in the fields of gene, genome and cellular editing, modulation, modification, engineering, regulation, repair and therapy to develop human pharmaceutical and biological preparations to be delivered or applied ex vivo to human cells for use in human therapeutics and diagnostic products and services; scientific study and research in the fields of gene, genome and cellular editing, modulation, modification, engineering, regulation, repair and therapy to develop human pharmaceutical and biological preparations to be delivered or applied ex vivo to human cells for use in human therapeutics and diagnostic products and services; design of bioinformatic algorithms and models for use in scientific and medical research in the fields of gene, genome and cellular editing, modulation, modification, engineering, regulation, repair and therapy to develop human pharmaceutical and biological preparations to be delivered or applied ex vivo to human cells for use in human therapeutics and diagnostic products and services

Trademark Events

Mar 22, 2024

New Application Entered